Rezultati - Atul Mehta
- Showing 1 - 20 results of 57
- Go to Next Page
-
1
-
2
Gaucher disease: haematological presentations and complications od Alison Thomas, Atul Mehta, Derralynn Hughes
Izdano 2014Revisão -
3
How we manage Gaucher Disease in the era of choices od Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran
Izdano 2018Revisão -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide od Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader
Izdano 2021Artigo -
15
-
16
-
17
-
18
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease od Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais, Hiroki Maruyama, Atul Mehta, Nina Skuban, Eva Krusinska, Raphael Schiffmann
Izdano 2020Artigo -
19
-
20
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis od Michael Beck, Derralynn Hughes, Christoph Kampmann, Sylvain Larroque, Atul Mehta, Guillem Pintos‐Morell, Uma Ramaswami, Michael L. West, Anna Wijatyk, Roberto Giugliani
Izdano 2015Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Disease
Fabry disease
Enzyme replacement therapy
Biology
Pediatrics
Gene
Glucocerebrosidase
Genetics
Surgery
Biochemistry
Cardiology
Intensive care medicine
Parkinson's disease
Cohort
Endocrinology
Mutation
Pathology
Adverse effect
Blood pressure
Chemistry
Gastroenterology
Globotriaosylceramide
Heart failure
Immunology
Renal function
Cardiomyopathy
Clinical endpoint
Clinical trial